- Home
- NISN vs TENX Comparison
NISN vs TENX Comparison
Compare NISN & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NISN
- TENX
- Stock Information
- Founded
- NISN 2005
- TENX 1967
- Country
- NISN China
- TENX United States
- Employees
- NISN N/A
- TENX N/A
- Industry
- NISN Metal Fabrications
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- NISN Industrials
- TENX Health Care
- Exchange
- NISN Nasdaq
- TENX Nasdaq
- Market Cap
- NISN 23.5M
- TENX 21.6M
- IPO Year
- NISN 2016
- TENX N/A
- Fundamental
- Price
- NISN $3.96
- TENX $6.08
- Analyst Decision
- NISN
- TENX Strong Buy
- Analyst Count
- NISN 0
- TENX 3
- Target Price
- NISN N/A
- TENX $16.00
- AVG Volume (30 Days)
- NISN 62.2K
- TENX 9.3K
- Earning Date
- NISN 04-29-2025
- TENX 05-14-2025
- Dividend Yield
- NISN N/A
- TENX N/A
- EPS Growth
- NISN N/A
- TENX N/A
- EPS
- NISN 1.43
- TENX N/A
- Revenue
- NISN $340,219,546.00
- TENX N/A
- Revenue This Year
- NISN N/A
- TENX N/A
- Revenue Next Year
- NISN N/A
- TENX N/A
- P/E Ratio
- NISN $18.96
- TENX N/A
- Revenue Growth
- NISN 8.05
- TENX N/A
- 52 Week Low
- NISN $3.14
- TENX $2.77
- 52 Week High
- NISN $22.55
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- NISN 37.20
- TENX 56.92
- Support Level
- NISN $4.38
- TENX $6.00
- Resistance Level
- NISN $4.84
- TENX $6.31
- Average True Range (ATR)
- NISN 0.54
- TENX 0.26
- MACD
- NISN -0.02
- TENX 0.03
- Stochastic Oscillator
- NISN 3.91
- TENX 65.88
About NISN NiSun International Enterprise Development Group Co. Ltd.
NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.